Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nu Skin Enterprises Reports First-Quarter 2006 Results
Company reports revenue of $265.8 million and a loss per share of $0.18 with net loss of $12.8 million and $0.18, compared to net income of $17.7 million and earnings per share of $0.25 during the first quarter of 2005.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- The Hain Celestial Group Announces Third Quarter Sales and Earnings
Company reports sales of $196.4 million in its third quarter, compared to prior year's $161.3 million, with net income of $9.7 million, versus the prior year's $7.7 million.
- The Hain Celestial Group Announces Third Quarter Sales and Earnings
Company reports sales of $196.4 million in its third quarter, compared to prior year's $161.3 million, with net income of $9.7 million, versus the prior year's $7.7 million.
- SunOpta Announces First Quarter Results
Company reports revenues of $133,312,000 as compared to $86,223,000 in the first quarter of the prior year, led by a 52.5% increase in revenues within the Company's vertically integrated natural and organic food operations, with net income of $3,012,000 or $0.053 per diluted common share as compared to $6,605,000 or $0.116 per diluted common share in the prior year.
- SunOpta Announces First Quarter Results
Company reports revenues of $133,312,000 as compared to $86,223,000 in the first quarter of the prior year, led by a 52.5% increase in revenues within the Company's vertically integrated natural and organic food operations, with net income of $3,012,000 or $0.053 per diluted common share as compared to $6,605,000 or $0.116 per diluted common share in the prior year.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Sunwin International Neutraceuticals Forms a Canadian Subsidiary to Distribute Chinese Herb-Based Medicines
Company has formed a wholly owned subsidiary in Canada, Sunwin (Canada) Pharmaceuticals, Limited, in order to market its Chinese herb-based medicines, including Hypericin, Honeysuckle, Angelica, Chrysanthemum, Epimedium, and Dandelion, throughout Canada
- Sunwin International Neutraceuticals Forms a Canadian Subsidiary to Distribute Chinese Herb-Based Medicines
Company has formed a wholly owned subsidiary in Canada, Sunwin (Canada) Pharmaceuticals, Limited, in order to market its Chinese herb-based medicines, including Hypericin, Honeysuckle, Angelica, Chrysanthemum, Epimedium, and Dandelion, throughout Canada
- Herbalife Ltd. Announces First-Quarter Results
Company reports net sales of $455.8 million with net income of $38.7 million, or $0.53 per diluted share, compared to $13.3 million, or $0.19 per diluted share in 2005.
- Herbalife Ltd. Announces First-Quarter Results
Company reports net sales of $455.8 million with net income of $38.7 million, or $0.53 per diluted share, compared to $13.3 million, or $0.19 per diluted share in 2005.
- GNC Corporation Reports First Quarter 2006 Financial Results
Company reports EBITDA of $37.5 million compared to $27.9 million in the first quarter of 2005, as net income for the first quarter of 2006 increased to $11.4 million compared to $2.7 million in the first quarter of 2005.
- GNC Corporation Reports First Quarter 2006 Financial Results
Company reports EBITDA of $37.5 million compared to $27.9 million in the first quarter of 2005, as net income for the first quarter of 2006 increased to $11.4 million compared to $2.7 million in the first quarter of 2005.
- Wild Oats Markets, Inc. Reports First Quarter 2006 Results
Company reports net sales of $298.4 million, compared to $278.1 million in the first quarter of 2005, with net income of $2.9 million, or $0.10 per share, compared to a net loss of $1.2 million or $0.04 per share in last year's first quarter.
- Wild Oats Markets, Inc. Reports First Quarter 2006 Results
Company reports net sales of $298.4 million, compared to $278.1 million in the first quarter of 2005, with net income of $2.9 million, or $0.10 per share, compared to a net loss of $1.2 million or $0.04 per share in last year's first quarter.
- Natrol Elects Ralph Simon to Its Board of Directors
Company announces the election of Ralph Simon to its Board of Directors, bringing background and experience in the global entertainment and mobile content industry.
- Natrol Elects Ralph Simon to Its Board of Directors
Company announces the election of Ralph Simon to its Board of Directors, bringing background and experience in the global entertainment and mobile content industry.
- Natrol Elects Ralph Simon to Its Board of Directors
Company announces the election of Ralph Simon to its Board of Directors, bringing background and experience in the global entertainment and mobile content industry.
- Natrol Elects Ralph Simon to Its Board of Directors
Company announces the election of Ralph Simon to its Board of Directors, bringing background and experience in the global entertainment and mobile content industry.
- S. BLACK and MUNTONS Form New Alliance
- S. BLACK and MUNTONS Form New Alliance
- S. BLACK and MUNTONS Form New Alliance
- S. BLACK and MUNTONS Form New Alliance
- S. BLACK and MUNTONS Form New Alliance
- S. BLACK and MUNTONS Form New Alliance
- S. BLACK and MUNTONS Form New Alliance
- Enzymotec Granted New US Patent on Lyso-phospholipids
Company has announced that it has received US-approval for its proprietary enzymatic technology for producing Lyso-phospholipids.
- Enzymotec Granted New US Patent on Lyso-phospholipids
Company has announced that it has received US-approval for its proprietary enzymatic technology for producing Lyso-phospholipids.
- Enzymotec Granted New US Patent on Lyso-phospholipids
Company has announced that it has received US-approval for its proprietary enzymatic technology for producing Lyso-phospholipids.
- Enzymotec Granted New US Patent on Lyso-phospholipids
Company has announced that it has received US-approval for its proprietary enzymatic technology for producing Lyso-phospholipids.
- Natural Health Trends Corp. Announces Fourth Quarter and Twelve Months 2005 Results
Company reports Q4 sales of $43.7 million, up 20% from the $36.3 million for the comparable period a year ago, with a net loss of $6.3 million, or $0.88 per fully diluted share, compared to a net loss of $0.8 million or $0.12 per fully diluted share a year ago.
- Natural Health Trends Corp. Announces Fourth Quarter and Twelve Months 2005 Results
Company reports Q4 sales of $43.7 million, up 20% from the $36.3 million for the comparable period a year ago, with a net loss of $6.3 million, or $0.88 per fully diluted share, compared to a net loss of $0.8 million or $0.12 per fully diluted share a year ago.
- Hansen Natural Reports Record First Quarter Sales And Profits
Company reports gross sales of $137.8 million compared to $73.0 million a year earlier, with net income of $21.1 million, or $0.84 per diluted share, compared $8.8 million or $0.37 per diluted share for the same quarter last year.
- Hansen Natural Reports Record First Quarter Sales And Profits
Company reports gross sales of $137.8 million compared to $73.0 million a year earlier, with net income of $21.1 million, or $0.84 per diluted share, compared $8.8 million or $0.37 per diluted share for the same quarter last year.
- Omega Protein Reports 2006 First Quarter Results
Company reports net income of of $2.5 million (10 cents per share), compared with net income of $107,000, or 0 cents a share, for the first quarter of the previous year, on revenues of $28.3 million this year, versus revenues of $23.8 million for the 2005 comparable quarter.
- Omega Protein Reports 2006 First Quarter Results
Company reports net income of of $2.5 million (10 cents per share), compared with net income of $107,000, or 0 cents a share, for the first quarter of the previous year, on revenues of $28.3 million this year, versus revenues of $23.8 million for the 2005 comparable quarter.
- Advitech Announces Its First-Quarter Highlights And Financial Results
Company reports quarterly net loss of $361,872 or $0.01 per share, compared to a net loss of $671,269 or $0.01 per share for the same period in 2005, with cash and cash equivalents totalling $730,229, compared to $686,742 as at December 31, 2005.
- Advitech Announces Its First-Quarter Highlights And Financial Results
Company reports quarterly net loss of $361,872 or $0.01 per share, compared to a net loss of $671,269 or $0.01 per share for the same period in 2005, with cash and cash equivalents totalling $730,229, compared to $686,742 as at December 31, 2005.
- MGP Ingredients Announces Fiscal 2006 Third Quarter Results
Company reports net income of $2,083,000, or $0.13 in basic earnings per share compared with net income of $1,627,000, or $0.10 per share, for the third quarter of fiscal 2005, on net sales of $79,422,000 versus net sales of $71,186,000 in the prior year period.
- MGP Ingredients Announces Fiscal 2006 Third Quarter Results
Company reports net income of $2,083,000, or $0.13 in basic earnings per share compared with net income of $1,627,000, or $0.10 per share, for the third quarter of fiscal 2005, on net sales of $79,422,000 versus net sales of $71,186,000 in the prior year period.
- Mannatech Reports First Quarter Results
Company reports sales of $99.0 million, compared to $85.1 million prior year, with net income of $5.9 million from $4.7 million last year.
- Mannatech Reports First Quarter Results
Company reports sales of $99.0 million, compared to $85.1 million prior year, with net income of $5.9 million from $4.7 million last year.
- Cognis acquires Norwegian manufacturer of high-quality omega-3 fish oils
Cognis announces that it will acquire Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry. The Napro Pharma product portfolio further strengthens Cognis’ Nutrition & Health Strategic Business Unit as a leading supplier of natural-source ingredients sold worldwide for the dietary supplement and functional food markets. The transaction is expected to be completed by end of June, 2006.
- Cognis acquires Norwegian manufacturer of high-quality omega-3 fish oils
Cognis announces that it will acquire Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry. The Napro Pharma product portfolio further strengthens Cognis’ Nutrition & Health Strategic Business Unit as a leading supplier of natural-source ingredients sold worldwide for the dietary supplement and functional food markets. The transaction is expected to be completed by end of June, 2006.
- Lifeline Therapeutics, Inc. Announces Q3 FY 2006 Financial and Operating Results
Company reports revenues of $1,390,623 and a loss of $(670,911), or $(0.03) per share, for its third fiscal quarter, compared to $25,819, resulting in a loss of $(1,519,829), or $(0.09) per share prior year.
- Lifeline Therapeutics, Inc. Announces Q3 FY 2006 Financial and Operating Results
Company reports revenues of $1,390,623 and a loss of $(670,911), or $(0.03) per share, for its third fiscal quarter, compared to $25,819, resulting in a loss of $(1,519,829), or $(0.09) per share prior year.
- Natrol, Inc. Announces First Quarter Results
Company reports net sales of $17.0 million compared to $17.7 million in the same period a year ago, while the net income was $73,000, compared to a loss of $592,000 in the prior year.
- Natrol, Inc. Announces First Quarter Results
Company reports net sales of $17.0 million compared to $17.7 million in the same period a year ago, while the net income was $73,000, compared to a loss of $592,000 in the prior year.
- Lifeway Foods Reports Record 1st Quarter 2006 Results
Company reports sales of $6,003,023 compared to $4,656,860 during the same period a year ago with operating income of $1,406,372 in the first quarter 2006, compared to $923,724 during the same period a year ago.
- Lifeway Foods Reports Record 1st Quarter 2006 Results
Company reports sales of $6,003,023 compared to $4,656,860 during the same period a year ago with operating income of $1,406,372 in the first quarter 2006, compared to $923,724 during the same period a year ago.
- AMS Health Sciences, Inc. Announces First Quarter 2006 Financial Results
Company reports net sales of $2,351,713 compared to $4,050,758 prior year, with a profit from continuing operations of $19,401 for the quarter, versus loss of $1,314,605 for the same period in 2005.
- AMS Health Sciences, Inc. Announces First Quarter 2006 Financial Results
Company reports net sales of $2,351,713 compared to $4,050,758 prior year, with a profit from continuing operations of $19,401 for the quarter, versus loss of $1,314,605 for the same period in 2005.
- PacificHealth Laboratories Reports First Quarter Results
Company reports revenues of $1,575,396 for the quarter ended March 31, 2006 compared to revenues of $997,661 for the same period in 2005, with net income of $2,619,293, or $0.22 per share fully diluted, versus a net loss attributable to common stockholders of ($724,679), or ($0.07) per share, for the same period in 2005.
- PacificHealth Laboratories Reports First Quarter Results
Company reports revenues of $1,575,396 for the quarter ended March 31, 2006 compared to revenues of $997,661 for the same period in 2005, with net income of $2,619,293, or $0.22 per share fully diluted, versus a net loss attributable to common stockholders of ($724,679), or ($0.07) per share, for the same period in 2005.
- Allergy Research Group, Inc. Reports First Quarter Results
Company reports revenues of $4,265,527 for the quarter compared to $4,111,173 for the same period last year, with net income of $325,683 compared to $319,533 prior year.
- Allergy Research Group, Inc. Reports First Quarter Results
Company reports revenues of $4,265,527 for the quarter compared to $4,111,173 for the same period last year, with net income of $325,683 compared to $319,533 prior year.
- Nutrition 21 Reports Results For The Third Quarter Of Fiscal 2006
Company reports revenues of $2.5 million compared to $2.4 million for the same period last year, with a net loss of $2.3 million, or ($0.06) per diluted share, compared to a net loss of $1.9 million, or ($0.05) per diluted share, in the third quarter of fiscal 2005.
- Nutrition 21 Reports Results For The Third Quarter Of Fiscal 2006
Company reports revenues of $2.5 million compared to $2.4 million for the same period last year, with a net loss of $2.3 million, or ($0.06) per diluted share, compared to a net loss of $1.9 million, or ($0.05) per diluted share, in the third quarter of fiscal 2005.
- Forbes Medi-Tech announces Financial Results for the Quarter ended March 31, 2006
Company reports total revenue of $0.9 million for the quarter versus $1.0 million for same period last year, with net income of $0.09 per share for the quarter compared to a net loss per share of $0.07 for same period last year.
- Forbes Medi-Tech announces Financial Results for the Quarter ended March 31, 2006
Company reports total revenue of $0.9 million for the quarter versus $1.0 million for same period last year, with net income of $0.09 per share for the quarter compared to a net loss per share of $0.07 for same period last year.
- NutraCea Reports First Quarter Financial Results
Company reports total revenues of $3,781,543, compared to total revenues of $459,314 for the first quarter of 2005, with a net loss of $233,570 or $(0.00) per share, compared to a net loss of $864,693, or $(0.02) per share in 2005.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Lake Forest, California – Collagen Nutraceuticals (CN) announces the filing of worldwide patent protection for their rooster and hen’s comb HA extraction process and biofermentation method. The advanced rooster and hen’s comb HA extraction technique is utilized in manufacturing PureHA™, a natural source of hyaluronic acid that is colorless, odor-neutral and water-soluble.
PureHA™ is a 100% natural bioavailable food source that is easily formulated and provides an excellent level of nutrients. Studies have shown that hyaluronan is particularly effective for lubrication of joints, skin and eyes. PureHA™ can also be used for topical skin formulation to support healthy skin.
For more information call 949-660-1673 or email c2n@kolla2.com
|